GLUCOCORTICOIDS AND MINERALOCORTICOIDS are involved in the control of a variety of physiological processes, including reproduction, metabolism, salt balance, inflammation, and immunity (5) . Corticosteroids also play a role in cell proliferation and differentiation (15) , as well as the development and maturation of several tissues, such as lung, small intestine, and pituitary (16, 42, 54) . The classic action of corticosteroids is mediated through glucocorticoid (GR) and mineralocorticoid (MR) receptors that belong to the steroid receptor family (4, 55) . GR and MR work as ligand-dependent transcription factors (37) . In the absence of ligand, both receptors are present in the cytoplasm of the cells as multiprotein complexes containing heat shock proteins and immunophilins (7, 46) . Upon activation by hormone binding that leads to conformational activation, dissociation of heat shock proteins and dimerization, GR and MR are translocated into the nucleus where they bind to the glucocorticoid response elements (GRE) in the target gene promoter (35, 40) and enhance or inhibit mRNA, and ultimately protein, expression (1, 18) . In addition to their classic pattern of action, corticosteroids may mediate their effects through nongenomic pathways employing the membrane-associated classic receptors or nonclassic receptors (43) . Like other steroid receptors (estrogen, progesterone, and androgen receptor), GR and MR were created by a series of duplication events from a common ancestral receptor gene in vertebrates (55) . In vertebrates, the two paralogues (GR and MR) came from a single ancestral corticosteroid receptor gene in a large-scale gene duplication event more than 450 million years ago (12, 55) . Corticosteroid receptors share common steroid receptor domain structure of N-terminal domain (NTD), DNA-binding domain (DBD) and ligand binding domain (LBD) (19, 29) . Mammalian GR is expressed ubiquitously in almost all tissues, while MR expression is limited to epithelial cells of the kidney and gut, neuronal cells, and vascular smooth muscle cells (58) . Human GR is characterized by high affinity to dexamethasone, modest affinity to cortisol and corticosterone, and low affinity to aldosterone, deoxycorticosterone, and sex steroids. On the other hand, human MR has high and equivalent affinity for corticosterone, aldosterone, and cortisol (18) .
GR and MR have been well characterized in mammals, especially in rodents. In contrast, avian homologues of these two receptors are poorly understood, particularly from pharmacological and molecular perspectives. Functional studies of avian homologues of GR and MR were initiated years ago and continue to date (11) , resulting in identification of both receptors (12, 24, 47) , their expression profiles, and hypothalamopituitary-adrenal axis ontology in birds (26, 31, 47) . Only recently has the entire chicken GR (cGR) gene been cloned and sequenced (31) . The chicken MR (cMR) still remains partially cloned (47) , and both receptors require thorough functional and molecular characterization. Therefore, the aim of this paper was to functionally characterize chicken homologues of GR and MR. Here, we cloned the entire coding sequences of cGR and cMR, overexpressed them in Cos-7 cells, and characterized their transcriptional activity in response to GR and MR agonists and specific antagonists. Moreover, we specify the localization of cGR and cMR in unliganded and active states.
MATERIALS AND METHODS
Animals and tissue collection. All animal studies were conducted according to protocols approved by the Institutional Animal Care and Use Committee at the University of Maryland. Broiler strain chicken embryos (Ross) were purchased from Allen's Hatchery (Seaford, DE) and incubated in a 37.5°C in a humidified incubator until embryonic day 14 (e14) of the 21-day incubation period. For RNA and protein extraction, liver, kidney, whole brain, and the entire pituitaries (n ϭ 4) were isolated from e14 embryos, frozen in liquid nitrogen, and stored at Ϫ80°C. Rat liver tissue sample was obtained from Dr. T. W. Castonguay (University of Maryland, College Park, MD).
RNA isolation and RT-PCR. Total RNA was extracted from pituitaries and green monkey kidney cells (Cos-7) using RNeasy Mini kits (Qiagen, Valencia, CA) and quantified using the RiboGreen quantitation kit (Invitrogen, Carslbad, CA). The RT reactions (20 l) consisted of 1 g total RNA, 50 units Superscript III reverse transcriptase (Invitrogen), 40 units of an RNase inhibitor (Invitrogen), 0.5 mM dNTPs, and 100 ng of random hexamer primers or 50 M of anchored oligo(dT)-one-V primer (5=-CGGAATTCTTTTTTTTTTTTTTTTTTTTV-3=). PCRs were performed in 25-l reactions containing 20 mM Tris·HCl, pH 8.4, 50 mM KCl, 1.0 unit of Taq DNA polymerase (Invitrogen), 0.2 mM Mg 2ϩ , 10 pmol of each gene-specific primer, and 1 l of the RT reaction. Thermal cycling parameters were 1 cycle 94°C for 2 min, followed by 30 to 35 cycles of 94°C for 30 s, 56 to 58°C for 30 s, and 72°C for 1 to 3 min, with a final extension at 72°C for 8 min. Negative RT controls were run to ensure PCR accuracy and specificity. See Supplemental Table 1 in the online version of this article for primer sequences used to determined endogenous GR and MR mRNA levels in Cos-7 cells (hGR and hMR, respectively) and overexpressed levels of cGR and cMR mRNA.
Sequencing of the chicken homologue of mineralocorticoid receptor. Total RNA from e14 pituitaries and an RT-PCR-based strategy were employed to clone the cMR. Nucleotide sequence for cMR cDNA, including the whole coding sequence and portions of the 5=-and 3=-untranslated regions (UTR), was derived using primers sets initially based on partial sequence (47) of cMR (GenBank accession no. AF468211) and the chicken genome database predicted sequence (ENSGALG00000010035). With these primers, a series of overlapping PCR products was generated, while rapid amplification of cDNA ends (RACE) was used to characterize the 3=-UTR of cMR. 3=RACE PCR reaction was performed using anchored-oligo(dT)-one-V-based RT, and the anchored-oligo(dT)-one-V and gene-specific primer (5=-GCAAGCATTTCAGCACTTGA-3=). All PCR products were then sequenced by the University of Maryland's Center for Biosystems Research DNA Sequencing facility with AmpliTaq-FS DNA polymerase and Big Dye terminators with dITP in an Applied Biosystems DNA Sequencer (model 3100; Foster City, CA). Obtained sequences were then assembled into a single fragment of contiguous sequence. Biology Workbench (http://workbanch.sdsc.edu) and Blast (http:// www. ncbi.nlm.nih.gov/blast) programs were used to assemble and align the sequences for cMR with genomic sequence, to confirm predicted exon/intron boundaries, and to compare the nucleotide and predicted amino acid sequences of cMR with corresponding mammalian sequences.
Cloning of chicken glucocorticoid receptor for transient transfection. Forward primer (5=-CCGGAATTCCGGGCCACCATG-GATTCCAAAGAATTGCTTAAGTCGTCA-3=) containing an EcoRI restriction site (underlined) and Kozak sequence, and reverse primer (5=-CCGGAATTCCGGTCACTTCTGATGAAATAAGAGCTTCT-TTAT-3=), including EcoRI restriction site (underlined) were synthesized, according to the chicken glucocorticoid receptor (cGR) sequence (GenBank accession no. DQ227738, 31) and used for PCR with AccuPrime Pfx Super Mix (Invitrogen). The resulting PCR product encompassing the entire coding sequence of cGR was digested with EcoRI (Invitrogen) and cloned into mammalian expression vector Sport6.1 (Invitrogen) under control of porcine cytomegalovirus (pCMV). The orientation and sequence of the cGR coding sequence were then verified by sequencing using M13 forward and reverse primers.
Cloning of chicken mineralocorticoid receptor for transient transfection. Because of the size of the cMR gene, the coding sequence of cMR was directionally cloned in two pieces into pCMVSport6.1. Forward primers (5=-AATTCCGGACCGGCCACCATG-GAGAC AAAAGGATACCACAGCTAC-3= and 5=-AGAAGAAGT-GATGGGTATCCAGTT-3=), including a RsrII restriction site (underlined), Kozak sequence, and XbaI cut site (italic), respectively, and reverse primers (5=-TGGACACGTTTTCTGGAATG-3= and 5=-CCCAAGCTTGGGTCACTTCTTGTGAAAGTACAGGGGC-3=) containing a XbaI restriction site (italic) and a HindIII restriction site (underlined) were synthesized according to the cMR sequence (GenBank accession no. FJ808618) and used to generate two PCR products with AccuPrime Pfx Super Mix. The resulting two overlapping PCR fragments encompassing the complete cMR coding sequence were digested by appropriate restriction enzymes (Fermentas, Glen Burnie, MD, Invitrogen) and cloned directionally into pCMVSport6.1 and verified by sequencing with M13 forward and reverse primers.
Cell culture, transfection, and luciferase assay. Cell culture reagents were obtained from Invitrogen, while hormones and other chemicals were purchased from Sigma Aldrich (St. Louis, MO). Cos-7 cells (kindly provided by G. L. Hager, Laboratory of Receptor Biology and Gene Expression, Center for Cancer Research, National Institutes of Health, National Cancer Institute, Bethesda, MD) were grown in DMEM supplemented with 10% FBS and incubated at 37°C in air atmosphere containing 5% CO 2. For luciferase assay, Cos-7 cells were plated in 24-well plates at the density of 2 ϫ 10 5 cells/well and incubated overnight. Cells were then transfected with 1 g of cGR and/or cMR expression vector (pCMV-Sport6.1-cGR or/and pCMV-Sport6.1-cMR, respectively), 1 g of GRE-Luc reporter vector (pSV40-LTR-Luc, kindly provided by G. L. Hager), and 20 ng of Renilla plasmid (pRL-SV40, Promega, Madison, WI), for normalization of transfection efficiency, using Lipofectamine 2000 reagent (Invitrogen) and Opti-MEM I medium. The long-terminal repeat region of GRE-Luc reporter vector contains four consensus GRE sites. After 6 h, the transfection medium was replaced with DMEM/F12 (DMEM:Nutrient Mixture F12) supplemented with 0.1% BSA, and the cells were allowed to recover overnight. Twenty-four hours after transfection, serum-starved cells were incubated with various concentrations of corticosterone (CORT) or aldosterone (ALDO) (Sigma) and/or GR and MR antagonists [onapristone (ZK98299), kindly supplied by Schering AG (Berlin, Germany) and spironolactone, supplied by Sigma, respectively] for 24 h, as indicated. Subsequently, cells were harvested, and measurement of both firefly and Renilla luciferase activity was performed using dual luciferase reporter assay system (Promega), according to the manufacturer's protocol. The data were normalized for the activity of Renilla in each sample. For RNA and total protein extraction, cells were plated in 12-well plates at 8.2 ϫ 10 5 cells/well and transfected with 2 g of expression vector as described above. For cytoplasmic and nucleic fraction isolation, Cos-7 cells were grown in 10-cm plates until they reached 80% confluence, transfected with 24 g of expression vector, and incubated with 10
Total protein extraction. Lysis buffer containing 20 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1 mM PMSF, 1 ϫ phosphatase and proteinase inhibitors [Sigma and Thermo Fisher Scientific (Rockford, IL), respectively] was used to prepare the whole cell lysate of the Cos-7 cells or to homogenize 50 -100 mg of chicken or rat liver. Lysates/homogenates were centrifuged at 14,000 g for 10 min at 4°C, and the supernatants were collected and snap frozen in liquid nitrogen. Protein concentration was estimated by the Coomassie plus (Bradford) protein assay (Thermo Fisher Scientific).
Cytoplasmic and nuclear fractions. The cytoplasmic and nuclear fractions from Cos-7 cells were isolated according to the method of Dignam et al. (17) with modifications. Briefly, the cells were collected and washed once in PBS, and pelleted by centrifugation (10 min, 1,850 g). The resulting pellet was swollen and homogenized using a Dounce homogenizer in hypotonic buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.2 mM PMSF, and 0.5 mM DTT). The cytoplasmic fraction was collected by centrifugation (15 min, 3,300 g), and resulting pellets (nuclei) were lysed in a 1:1 mixture of low-salt buffer (20 mM HEPES pH 7.9, 25% glycerol, 1.5 mM MgCl2, 20 mM KCl, 0.2 mm EDTA, 0.2 mM PMSF, and 0.5 mM DTT) and high salt buffer (20 mM HEPES pH 7.9, 25% glycerol, 1.5 mM MgCl2, 1.4 M KCl, 0.2 mm EDTA, 0.2 mM PMSF, and 0.5 mM DTT). Nuclear fractions were collected by centrifugation (30 min, 25,000 g), and the high-salt buffer was removed using 10 kDa Microcon columns (Millipore, Billerica, MA). Protein concentration in cytoplasmic and nuclear fraction was estimated by the Bradford method (Thermo Fisher Scientific).
Western blot analysis. Protein extracts (9 g for whole cell lysate and cytoplasmic and nuclear fractions, and 50 g for tissues proteins) were subjected to SDS-PAGE under reducing conditions on 10% gels. Separated proteins were then transferred to PVDF membranes (Immobilon-P, Millipore) using a semidry electroblotting system (BioRad Laboratories, Hercules, CA) for 1.5 h at 16 -25 V in Tris-glycine buffer containing 20% methanol. Membranes were blocked with 5% nonfat dry milk for 2 h and incubated overnight with one of following antibodies: 1) mouse monoclonal anti-rat GR antibody GR49 -4 that recognizes chicken GR, as shown previously (21; To confirm the purity of cytoplasmic and nuclear fraction, the GR-and MR-probed membranes were stripped (100 mM 2-mercaptoethanol, 2% SDS and 62.5 mM Tris·HCl, pH 6.7) and reprobed with rabbit polyclonal lamin A/C antibody (1:250, Santa Cruz Biotechnology) and mouse monoclonal ␣-tubulin antibody (1: 500, Santa Cruz Biotechnology).
Immunocytochemistry. For GR and MR immunostaining, Cos-7 cells were directly plated on two-chamber slides, transfected with empty pCMV-Sport6.1, pCMV-Sport6.1-cGR, or pCMV-Sport-cMR, as described above and treated with 10 Ϫ8 M corticosterone overnight. The next day, the cells were fixed for 20 min with 4% freshly prepared paraformaldehyde in PBS (pH 7.4), permeabilized with 0.1% Triton X-100 in PBS for 8 min, and blocked with 5% normal goat serum in PBS for 30 min. Incubation with GR49 -4 (1:1,000, described above) or rMR1-18 1D5 (1:200) primary antibodies (described above) in PBS containing 2% normal goat serum was performed overnight. The slides were then incubated with rhodamine (TRITC)-conjugated AffiniPure goat anti-mouse IgG (1:200; Jackson ImmunoResearch Laboratories, West Grove, PA), counterstained with DAPI solution (5 ng/ml; Invitrogen), mounted in Fluoromount-G (Southern Biotech, Birmingham, AL), and visualized using an Observer Z.1 Axio fluorescent microscope with AxioVision 4.6 software (Carl Zeiss, Oberkochen, Germany) and an Axiovert 100 confocal microscope with LSM 3.99 software (Carl Zeiss). For the negative control, the primary antibodies were omitted during slide incubation.
Statistical analysis. All data were analyzed by one-or two-way ANOVA using the MIXED models procedure of SAS (SAS Institute, Cary, NC), and differences between groups were determined using the test of least significant difference (PDIFF; SAS). For EC 50 (half maximal response value) estimation, the data were first log-transformed to fit a linear regression curve.
RESULTS

Structure, cloning, and sequence analysis of chicken mineralocorticoid receptor gene.
Primer-directed RT-PCR and 3=-RACE were involved in sequencing of 3,799 bp of pituitaryderived cDNA corresponding to the complete coding region and portions of the 5=-and 3=-UTR of the chicken homologue of MR mRNA (GenBank accession no. FJ808618). The cMR gene, located on chromosome 4, consists of 8 coding exons ranging in size from 117 to Ͼ2,172 bp and spans in excess of 197 kb of the chicken genome (Fig. 1) . The sequenced cMR gene shares 98% homology with predicted MR (GenBank accession no. XM_420437) and contains 412 bp of noncoding sequence at the 5= end of the cMR gene. Moreover, obtained cMR sequence showed 99% homology with the previously partially sequenced MR gene that spans four exons at the 3= end of the gene (GenBank accession no. AF468211, 47). The one base pair difference in MR nucleotide sequence (C/T substitution) is probably due to different strains of broiler chicken used to isolate RNA. The C/T substitution in cMR does not cause any changes in amino acid sequence. Figure 1B presents a comparison of the number, order, and size of each exon and intron for chicken, human, mouse, and rat MR genes. The number, order, and size of cMR exons showed a high degree of similarity to mammalian MR gene; however, we were not able to identify the first noncoding exon that is present Figure 2 shows the amino acid sequence alignment of the chicken MR protein compared with corresponding proteins from human, mouse, and rat. cMR protein shows an overall high homology ranging from 77 to 82% compared with mammalian sequences, while the homology of the functional domains is much higher ( Table 1) . The homology between chicken MR and GR ranged from 22% to 64 and 94% for NTD, LBD, and DBD, respectively.
Cloning and sequencing of the expression vectors for cGR. Analysis of the cGR expression vector sequence obtained using M13 forward and reverse primers revealed two nucleotide differences in the cGR open-reading frame compared with GenBank deposit DQ227738. Substitution of C to T at position 556 of the coding sequence resulted in a serine to phenylalanine change at position 184 in the amino acid sequence. The second nucleotide substitution at position 2147 (G to A) did not affect the amino acid sequence. Compared with the partial sequence of cGR (GenBank accession no. AY029202, 47) that covers 2,076 to 2,277 bp and 691 to 757 amino acids of cGR cDNA and protein, respectively, our sequence shares 97% and 98% identities on nucleotide and protein levels, respectively. The 8 nucleotide substitutions between these two sequences are probably due to cGR gene polymorphisms among different chicken strains.
Analysis of the endogenous and overexpressed MR and GR levels in Cos-7 cells.
RT-PCR analysis showed that nontransfected Cos-7 cells (NT) expressed low levels of GR mRNA, but no MR expression was detected (see Supplemental Fig. 1A in the online version of this article). In contrast, transfection with 1 g of cGR or cMR expression vector (ϩcGR or ϩcMR, respectively) resulted in high levels of the corresponding mRNA as detected by PCR. No PCR product was detected after transfection with empty mammalian expression vector (ϩpSp) (Supplemental Fig. 1A ). Western blot analysis confirmed the PCR results. NT cells showed only a low level of GR protein. A band of similar size to Cos-7 endogenous and chicken and rat liver GR (95 kDa) was observed when Cos-7 cells were transfected with cGR (see Supplemental Fig. 1B in the online version of this article). For the MR, an intense band of the size of 119 kDa was obtained only in Cos-7 cells transfected with cMR expression vector and probed with rMR1-18 antibody. Unfortunately, using the rMR1-18 antibody, we failed to detect endogenous level of MR in chicken brain and kidney tissues (data not shown) probably due to low affinity of the antibody, lower MR protein expression, and/or increased instability of MR protein. As a negative control, we used chicken and rat liver, and as expected, both tissues showed no positive band for MR. Using MCR(C-19) antibody, we were not able to detect overexpressed cMR protein in Cos-7 cells, as well as endogenous MR in rat and chicken tissues (data not shown).
Dose-dependent activation of cGR-and cMR-driven GREluc reporter construct by costicosteroids.
To examine the transcriptional activity of chicken homologues of GR and MR, Cos-7 cells were transiently transfected with cGR or cMR expression vector and GRE-Luc reporter construct, and treated overnight with different doses of CORT or ALDO. ALDO maximally stimulated cGR transactivation at 10 Ϫ9 M, while 10 Ϫ7 M of CORT was required for maximal effect on cGR response. At 10 Ϫ7 M of both steroids, cGR transcriptional activity was significantly (P Ͻ 0.05) higher for CORT than for ALDO (Fig. 3A) . 10 Ϫ10 M of ALDO was able to induce maximal transcriptional activity of cMR, and no additional increase in activity was observed with increasing doses of ALDO. Even though a significant (P Ͻ 0.05) increase in cMR transactivation was observed at 10 Ϫ10 M CORT, a 100 times higher dose of this steroid was required to reach maximal cMR transcriptional activity (Fig. 3B) . Twofold dilution of both steroids (64 ϫ 10 Ϫ10 M for cGR and 64 ϫ 10 Ϫ11 for cMR) confirmed the transcriptional activity pattern for cGR and cMR (Fig. 3, C and D) . Half-maximal response values (EC 50 ) derived from the dose-response curves for both receptors are presented in Table 2 . CORT stimulated cGR and cMR transactivation with EC 50 of about 2.2 times higher compared with the EC 50 of ALDO. Moreover, comparison of EC 50 between cGR and cMR revealed that about 12.5 times lower doses of both steroids were required for activation of cMR than for cGR ( Table 2) .
Coexpression of both receptors in Cos-7 cells does not affect their transcriptional activity. It has been shown in mammals that heterodimerization between the two corticosteroid receptors (GR and MR) leads to increased DNA binding and alteration in DNA binding kinetics compared with either GR or MR homodimers (56) . To investigate whether heterodimerization of cGR and cMR will alter GRE-dependent transcription, different levels of both chicken receptor expression vectors were cotransfected into Cos-7 cells, and transcriptional activity was induced by low (32 ϫ 10 Ϫ11 M) and high (10 Ϫ8 M) doses of CORT. Coexpression of both cGR and cMR in Cos-7 cells resulted in comparable activity to that achieved by cGR or cMR alone, indicating that heterodimerization does not likely affect GR and MR transcriptional activity in the chicken (Fig. 4) . Similar results were obtained when coexpressed chicken corticosteroid receptors were treated with low and high (4 ϫ 10 Ϫ11 and 10 Ϫ9 M, respectively) doses of ALDO (data not shown).
Corticosteroid receptor antagonists decrease corticosteroid-induced activity. To investigate whether common mammalian GR and MR antagonists (ZK98299 and spironolactone, respectively) have similar effects on chicken homologues of GR and MR as they do in mammals, cGR-and cMR-transfected Cos-7 cells were pretreated for 3 h with different doses of ZK98299 or spironaloctone and then treated with 10 Ϫ8 M of CORT or 10 Ϫ10 M of ALDO, respectively (Fig. 5, A and B) .
Treatment with 10
Ϫ9 to 10 Ϫ7 M of ZK98299 resulted in a dose-related decrease in CORT-induced cGR activity. The highest dose of ZK98299 tested (10 Ϫ7 M) produced greater than 60% decrease in cGR activity, while no decline in cGR transcriptional activity was observed at the lowest dose of GR antagonist (10 Ϫ9 M) tested (Fig. 5A ). In the case of cMR, dose-independent attenuation of ALDO-induced activity by spironolactone was observed (Fig. 5B) . Spironolactone, at the dose of 10 Ϫ6 to 10 Ϫ8 M, produced a decrease in cMR transactivation that ranged from 34 to 22%, whereas the lowest dose of this antagonist (10 Ϫ9 M) has no antagonist properties and resulted in significant (P Ͻ 0.05) increase in cMR transactivation (Fig. 5B) . In contrast to ZK98299, spironolactone also showed agonist characteristics when administered alone. Treat- ment with spironolactone alone resulted in about 50% activation of cMR compared with ALDO alone (Fig. 5B) .
To verify specificity of the corticosteroid receptor antagonists, Cos-7 cells overexpressing cGR or cMR were pretreated with spironolactone and ZK98299, respectively, and treated with 10 Ϫ8 M of CORT subsequently (Fig. 5, C and D) . At doses ranging from 10 Ϫ9 to 10 Ϫ6 M, spironolactone was not able to block activation of cGR by CORT. Interestingly, when administered alone (10 Ϫ8 to 10 Ϫ7 M), spironolactone was a significantly (P Ͻ 0.05) better activator of cGR than CORT (Fig. 5C ). In contrast, ZK98299 showed high specificity to cGR, and pretreatment with ZK98299 had no effect on CORTdependent activation of cMR. Moreover, administered alone, this GR antagonist did not show any agonist properties toward cMR or cGR (Fig. 5) .
Cellular localization of cGR and cMR in inactive and active states.
Western blot analysis of cytoplasmic and nuclear fractions from NT and cGR overexpressing Cos-7 cells indicated the presence of GR protein on both cellular fractions under basal conditions and after treatment with 10 Ϫ8 M of CORT. NT cells had significantly higher levels of endogenous GR in the cytoplasmic fraction than in the nuclear fraction in both basal and CORT-treated cells (see Supplemental Fig. 2A in the online version of this article). Only Cos-7 cells that overexpressed cMR showed the band corresponding to MR protein that was present in both cellular fractions (see Supplemental  Fig. 2B in the online version of this article). To verify the purity of isolated cellular fractions, the blots stained for GR and MR protein were stripped and reprobed with antibodies specific to cytoplasmic (␣-tubulin) and nuclear (lamin A/C) proteins. The cytoplasmic fraction was enriched with ␣-tubulin-specific staining (data not shown), while lamin A/C staining was higher in the nuclear fraction than in the cytoplasmic fraction (see Supplemental Fig. 2C in the online version of this article).
To verify the localization of corticosteroid receptors in nontreated (basal) and CORT-treated cells, fluorescence immunocytochemistry (ICC) was performed in nontransfected and Cos-7 cells overexpressing cGR and cMR (Fig. 6) . To localize the nuclei, the cells were counterstained with DAPI. Nontransfected Cos-7 cells showed no positive immunostaining for both endogenous GR and MR in the basal state (Fig. 6 , A, D) and after CORT treatment (data not shown). In basal conditions, cells overexpressing cGR were characterized by strong immunostaining observed in cytoplasm and nuclei of the cells, whereas CORT treatment induced translocation of cGR into nuclei (Fig. 6B) . To localize cMR, the rMR1-18 1D5 antibody, which worked very well with denatured proteins (see Supplemental Figs. 1 and 2B) , was used. Fluorescence ICC on Cos-7 cells overexpressing cMR in basal conditions showed mainly positive immunoreaction in the cytoplasm of the cells.
Treatment with 10
Ϫ8 M CORT for 24 h resulted in very strong immunostaining in the nuclei and weak immunoreaction in the The GenBank accession no. for human, rat, mouse and chicken MR predicted amino acid sequences were: NP_000892, NP_037263, NP_001077375, and ACO37437, respectively. NTD, N-terminal domain; DBD, DNA-binding domain; LBD, ligand-binding domain. cytoplasm of the cells, indicating translocation of MR protein to the nucleus after steroid treatment (Fig. 6E) . Figure 6 , C and F presents photomicrographs of the negative control, in which the primary antibody was omitted, indicating specificity of the staining. Confocal microscope analysis confirmed the results from the fluorescent microscope (Supplemental Fig. 3 ).
DISCUSSION
The presence of chicken homologues of both corticosteroid receptors has been known for more than 10 years, but only recently has the entire cGR cDNA been cloned and sequenced (31) , while cMR remained only partially cloned (47) . In the present study, we cloned, sequenced, and characterized the chicken homologue of MR and overexpressed both genes in Cos-7 cells to functionally characterize them. The results from our experiments demonstrate that cGR and cMR code for functional receptor proteins than could be activated by corticosteroids and partially attenuated by corticosteroid receptor antagonists. We also showed that coexpression of cGR and cMR, and presumably heterodimerization, did not influence their transactivation properties and that ligand binding induced receptor translocation into the nucleus. To our knowledge, this is the first report characterizing the functional properties of chicken GR and MR.
Structure, cloning, and sequence analysis of cMR. The cMR gene consists of eight coding exons spanning more than 196 kb on chromosome 4. The genomic organization of cMR coding sequence is similar to the mammalian MR genes, while the UTR regions are significantly different. In contrast to chicken, human MR contains two untranslated exons in the 5=-UTR (64) , and rat MR has 3 untranslated exons (30) . Human, mouse, and rat MR genes are mapped to chromosomes 4 (4q31), 8, and 19 (19q11) , respectively, and span more than 340 kb of genomic DNA (1, 4, 30, 64) . Chicken MR has a significantly larger first exon (about 400 bp longer) compared with the corresponding mammalian exon 2 that may correspond to mammalian untranslated exon 1 and coding exon 2, but we cannot exclude the possibility that the chicken might have unidentified untranslated exons in the 5=UTR of the MR gene. The exact function of the 5=-noncoding exon in mammals is unknown, but a role in transcript stability and/or translational efficiency of MR has been suggested (46) . In contrast to human and rodent, cMR also contains a shorter 3=UTR. It has been shown that long 3=UTR are characteristic for steroid hormone receptor mRNAs (4, 25) . Arriza et al. (4) identified four potential polyadenylation sites in human MR. Therefore, it is possible that there are multiple polyadenylation sites also in the chicken 3=UTR, but using 3=RACE, we were able to identify only the closest one to the stop codon. Although, we did not identify any alternatively spliced variants during the course of cloning the cMR coding sequence, we cannot rule out that the cMR gene might give rise to multiple mRNA or protein isoforms due to presumable, but unidentified, 5-untranslated exons or alternative promoter usage. Similarly, cGR shows no alternative transcript or splice variants (31) . In contrast, the human MR gene codes for two mRNA transcript variants that are controlled by two promoters (65) . Moreover, two additional splice variants are formed by a 12-bp insertion at the 3= end of the third exon/intron junction (8) and by skipping exon 5 and/or 6 in human MR (66) . In rat MR, three distinct mRNA transcripts differing at the 5=UTR but encoding the same protein have been observed (30) . Furthermore, deletion of 10 bp, resulting in truncation of the LBD in rat MR and differential expression of rat transcript variants in response to neuronal stress, have been also reported (27, 67) . Moreover, mammalian mRNA isoforms of MR show tissue-related expression (46, 59, 67) . The predicted amino acid sequence for cMR exhibits high homology with corresponding mammalian proteins, especially in the DBD and LBD. DBD, which is responsible for DNA binding and nuclear export, and contains a nuclear localization signal (NLS) 3, shares about 90% homology among human steroid receptors (19, 29, 46) . LBD, which share 60% homology between human steroid receptors and 85% homology across species, plays a role in ligand-dependent transcriptional activation and receptor dimerization (19, 29, 46) . NLS2 is located within the LBD. NTD is the least conserved domain and shares less than 15% homology with other steroid hormone receptor NTD domains. However, it is evolutionary conserved among species (more than 50% homology) (46) . NTD contains two transactivation domains (AF1a and AF1b) and NLS1 (46) . Chicken MR codes for a 986 amino acid protein that is 2, 5, and 6 amino acids longer than human, rat, and mouse MR, respectively. cMR is significantly longer than cGR due to a large amino-acid terminus. Like humans and rodents, chicken GR and MR share high homology between their DBDs (94%) and LBDs (64%), while the homology between cGR and cMR NTDs is less than 22%.
Overexpression of cGR and cMR in Cos-7 cells. RT-PCR and Western blot results confirmed the expression of cGR and cMR on the mRNA and protein level. Surprisingly, Cos-7 cells, which are derivative from CV1 cells (monkey kidney cells) lacking endogenous GR and MR (4, 34) , expressed low levels of GR mRNA and protein. Similarly to previous reports (4, 34) , no endogenous MR was detected in Cos-7 cells. On the protein level, overexpression of cMR resulted in one protein band, detected only in Cos-7 cells overexpressing cMR. With MCR (C-19) antibody, we were not able to detect chicken protein, while rMR1-18 1D5 antibody detected one protein band of 119 kDa. The sequence of the rMR1-18 peptide is identical between rat, human, and mouse sequences (20) , and 17 amino acids from rMR1-18 peptide are identical with (7) and Clyne et al. (14) observed that human MR expressed in Sf9 cells produced proteins ranging in size from 110 to 130 kDa due to posttranslational modification. Human MR is phosphorylated at T735, S737, and 600 (S601 in rat) (2), sumoylated at K89, K399, K428, K494, and K953, ubiquitinated at K367 and K715 and acetylated at K677 (46, 59) . Phosphorylation of T735 and S737 located close to LBD of hMR has been suggested to contribute to the domain conformational changes, while phosphorylation of S600 seems to play a role in the receptor subcellular shuttling (59) . Overall, it has been shown that phosphatase inhibitor treatment suppresses the liganddependent nuclear translocation of MR and reduces its DNA binding activity (44) . All chicken corresponding posttranslational modification sites (S606, T737, and S739 for phosphorylation, K93, 399, 428, 499, and 955 for sumoylation, K369
and 689 for ubiquitination and acetylation, respectively) are conserved compared with human MR, except for ubiquitination site K715. In chicken MR, this corresponding residue is substituted by T (T717). Such high conservation between human and chicken posttranslational modification sites suggests that chicken MR protein could also be modified, leading to higher observed molecular weight on the SDS-PAGE gel. However, all potential or suggested modification sites in chicken MR still need to be verified experimentally.
Dose-dependent activation of cGR and cMR-driven GRE-luc reporter construct by corticosteroids. Changes in GRE-Luc activity in response to corticosteroid hormones indicate that overexpressed chicken GR or MR in Cos-7 cells encode functional steroid hormone receptor proteins. Transient transfection of cGR or cMR allowed us to evaluate their steroidbinding potential. cGR and cMR were activated by both CORT and ALDO in a dose-dependent manner. The magnitude of response was about twofold higher for cGR than for cMR. It has been shown previously that in different corticosteroid- response promoters, gene transcription stimulated by GR may be 10 -20 times greater than that mediated by MR (49) . Additionally, in CV1 cells that were used to derive the Cos cell line, MR response exhibited only 20% of the GR maximal response (50) , while in an epithelial cell line (LLC-PK1) or hippocampal cell line (RN33B), the stimulation reached about 40% of GR effects (32) . McKenna et al. (38) indicated that cell-specific factors, such as coactivators and corepressors that interact with AF-1, are likely to be responsible for different levels of corticoid receptor stimulation. The Nterminal end of hGR has been characterized to strongly potentiate the hormonal response, whereas the N-terminal end of hMR protein has been shown to exert an inhibitory effect on synergistic activity mediated by DBD and LBD of both receptors (49) . Moreover, it has been shown only for hGR that induction of transcription from a promoter with two or more upstream GRE was 10 -20-fold greater compared with similar promoter with only one GRE (53, 62) , due to the presence of AF-1 in the hGR protein sequence (13) . Comparison of the cGR and hGR sequences showed that cAF-1 located in the DBD of GR shares about 61% homology with the human corresponding sequence (amino acids 77 to 262 of hGR). On the other hand, Arriza et al. (4) reported that GR and MR can transactivate the MMTV promoter with equivalent effects.
Analysis of the corticosteroid concentration required for maximal stimulation of cGR and cMR revealed that for both receptors, about a 10-fold lower level of ALDO was needed than CORT. Since, Cos-7 cells have no endogenous 11␤-hydroxysteroid dehydrogenase II activity (51), the glucocorticoid signaling pattern cannot be explained by this enzyme activity. The activation pattern of cGR and cMR corresponds to the endogenous level of CORT and ALDO in chickens. It has been shown that chickens have about 10-fold higher levels of CORT than ALDO (47) . A similar pattern is observed in mammals (22) . Our results indicate that both cGR and cMR are highly activated by glucocorticoids and mineralocorticoids. It has been shown that both synthetic and endogenous corticosteroids are able to bind to both receptors, due to significant homology between corticosteroid receptor LBD (4). However, only mammalian MR shows significant and high affinity for both glucocorticoids and mineralocorticoids, while GR binds only glucocorticoids with high affinity (4, 6, 33) . In contrast to our data, Arriza et al. (4) observed that hGR was not activated even by supraphysiological concentrations of ALDO. Lind et al. (33) reported that V571M substitution in human GR increased "MR-like" characteristics and led to higher mineralocorticoid affinity. Even though cGR shows MR-like properties toward ALDO, it seems unlikely that it is caused by an amino acid substitution in GR LBD. Sequence analysis of cGR revealed a lack of mutation at position V566 that corresponds to human V571. In agreement with the present data, hMR has been shown to be activated by lower doses of ALDO and high doses of glucocorticoids (49) . Moreover, at low doses of corticosteroids, hMR showed higher activation by ALDO. However, in contrast to our results, at higher doses of steroids, glucocorticoids led to higher activation of hMR than mineralocorticoids (49) . Analysis of the EC 50 values revealed that in the case of chicken GR and MR, a 2.3-fold higher EC 50 for CORT than ALDO was estimated. In contrast, human MR EC 50 for CORT was 15-fold greater than for ALDO, but for hGR, EC 50 was 5-fold lower for cortisol than for ALDO (49) .
Glucocorticoid and mineralocorticoid receptors evolved from one ancestral corticoid receptor through gene duplication events millions of years ago (12, 55) . Ancient corticosteroid receptor (AnsCR) was activated by both ALDO and glucocorticoids and was similar to the MR of tetrapods and teleosts (12) . On the protein level, cGR and cMR share 65% and 76% identities, respectively, with AnsCR ligand binding domain (GenBank accession no. DQ382342). On the functional level, cGR and cMR overexpressed in Cos-7 cells exhibit similar characteristics to elasmobranch (Chondrichthyes) MR. In elasmobranchs, both receptors are activated by both glucocorticoids and mineralocorticoids (12) . Substitution of S at position 106 and L at position 111 to P and Q, respectively, in the AnsCR LBD converts the AnsCR-MR like receptor to a modern GR phenotype (12) . Similarly to AnsCR, cMR contains S and L in corresponding positions in LBD (S845 and L850), whereas in cGR, corresponding positions are replaced by P and Q (P632 and Q637). In summary, even though cGR protein resembles the modern, mammalian GR, it shows different pharmacological characteristics than the mammalian GR, whereas cMR behaves similarly to mammalian counterparts.
Coexpression of both receptors in Cos-7 cells does not affect their transcriptional activity. Many physiological studies suggest that the two corticosteroid receptors, which have been shown to be colocalized in many cell types, interact functionally with each other (10, 56 -57) . It has been shown previously in mammals that heterodimerization of GR and MR depends on the amount of the receptors and is affected by ligand concentration (39, 41, 57) . In our case, there was no effect of coexpression of both receptors on CORT-dependent transcriptional activity. In contrast, nanomolar cortisol concentration treatment of coexpressed mammalian corticosteroid receptors resulted in synergistic increases in transactivation compared with each of the receptors alone, but increasing ligand concentration abrogated the effect (34, 56 -57) . On the other hand, Liu et al. (34) showed that coexpressed MR had an inhibitory effect on GR transcriptional activity in CV1 cells. Changes in DNA binding kinetics of coexpressed receptors compared with each receptor alone has been shown to take place during heterodimerization of corticosteroid receptors (56 -57) . Fluorescence resonance energy transfer analysis indicated that heterodimerization occurs after the ligand-dependent activation and translocation each of the corticosteroid receptors into the nucleus (39, 41) . Two residues of rat MR (R643 and D645) and GR (R479 and D481) in the zinc finger region of DBD have been identified to form R-D salt bridges involved in heterodimerization (34) . R and D residues are located in highly conserved regions of both receptors (DBD) among mammalian species and chicken homologues, which suggest that chicken GR and MR are likely to form heterodimers.
Corticosteroid receptor antagonists decrease corticosteroid-induced activity. Our results indicate that the GR antagonist ZK98299 decreased CORT-dependent cGR activation in a dose-dependent fashion and showed specificity to cGR. ZK98299 is a type I progesterone antagonist (52) that has the ability to bind to GR, but not to MR, in contrast to other known GR antagonists, such as RU486 (63) .
We also evaluated the MR antagonist spironolactone, which had both agonist and antagonist properties to cMR, and could also be characterized as a potent activator of cGR, especially at higher doses. Similarly to mammals (14) , spironolactone showed relatively low anti-cMR activity and nonselectivity to the chicken receptor. Only the highest dose of this antagonist was able to significantly reduce the ALDO-dependent activation of cMR, but at the same time, at higher doses (10 Ϫ6 and 10 Ϫ7 M), spironolactone induced greater GR transcriptional activity when administered alone or together with CORT than CORT alone. Other MR antagonists, so far characterized, have been shown to have only partial anti-MR properties (28, 45) . To our knowledge, no MR antagonists other than spironolactone have been tested in chickens. Both corticosteroid receptor antagonists (spironolactone and ZK98299) have been shown to have physiological effects in the chicken. ZK98299 has been shown to completely block the CORT-mediated inhibition of basal and CRF-stimulated ACTH secretion in chicken e20 pituitary cells (9) , and the CORT-induced increase in growth hormone (GH) secretion by e12 pituitary cells (23), whereas spironolactone was able to only partially block the CORTdependent GH secretion by e12 pituitary cells (23) . Our results suggest that ZK98299 can be used to block the cGR receptor, while results obtained by using spironolactone should be interpreted with caution.
Cellular localization of cGR and cMR. To observe the localization pattern of cGR and cGR, we performed ICC on Cos-7 cells overexpressing the chicken receptors. First, we verified that the selected antibodies could detect chicken receptor protein in nuclear and cytoplasmic fractions of Cos-7 cells overexpressing the receptors. Gr49 -4 and MR1-18 antibodies were able to detect cGR and cMR protein in nuclear and cytoplasmic fractions as shown by Western blot analysis. We were not able to detect endogenous levels of GR in Cos-7 cells by ICC, probably because of very low levels of this receptor in single cells. In the unliganded state, overexpressed cGR was localized in cytoplasm and nuclei of the cells, while cMR was mainly found in the cytoplasm of the Cos-7 cells. For comparison, unliganded rat GR and human MR overexpressed in insect cells mainly resided in the cytoplasm (2-3, 7, 35, 61) , while rabbit MR is present in cytoplasm and nuclei in the absence of ligand (36) . Fluorescent and confocal microscopic analysis showed that like mammals, chicken corticosteroid receptors are translocated into the nucleus after corticosteroid treatment (2-3, 36, 61) . It has been shown in mammals that micromolar doses of CORT induced translocation of both receptors with the same time course, whereas nanomolar doses of this steroid led to faster accumulation of MR in nuclei than GR (39) . Furthermore, after ligand binding, mammalian MR is translocated into nucleus in response to NLS (59) . There are three known NLS in human MR (60) , Sequence comparison between chicken and human MR revealed that there is 84.6%, 93%, and 100% homology between human and chicken NLS1, NLS2, and NLS3, respectively.
Perspectives and Significance
Corticosteroids are involved in the regulation of many physiological functions, from fishes to mammals. Thus, it is important to study their physiological and molecular pathways in lower vertebrates to better understand their role in highervertebrate physiology. In this article, we characterized the transcriptional activity of avian homologues of GR and MR. We found that cGR and cMR code for functional proteins that can induce transcription of a GRE-driven reporter in a corticosteroid dose-dependent manner. Further, we observed that coexpression of both chicken corticosteroid receptors did not affect their transactivation properties and that transcriptional activities of both receptors were at least partially attenuated by common corticoid receptor antagonists. A GR antagonist, ZK98299, was found to be specific for cGR, while the MR antagonist spironolactone had agonist properties toward both cMR and cGR. We were able to determine cellular localization of both corticosteroid receptors and their steroid-induced translocation into the nucleus. Taken together, we believe that our findings will provide a better understanding of the physiological role and action of chicken corticosteroid receptors in avian species. Moreover, our data could be helpful in better understanding steroid receptor evolution and conservation in vertebrates.
